Inactive Instrument

Peregrine Pharmaceuticals Share Price Nasdaq

Equities

US7136613046

Pharmaceuticals

Sales 2024 * 139M 11.6B Sales 2025 * 164M 13.68B Capitalization 524M 43.69B
Net income 2024 * -20M -1.67B Net income 2025 * -11M -918M EV / Sales 2024 * 3.77 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 3.19 x
P/E ratio 2024 *
-26 x
P/E ratio 2025 *
-44 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 98.9%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 60 30/20/30
Director of Finance/CFO 50 01/18/01
Chief Tech/Sci/R&D Officer - 01/99/01
Members of the board TitleAgeSince
Director/Board Member 59 27/17/27
Chairman 78 27/17/27
Director/Board Member 68 25/19/25
More insiders
Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO). The Company provides a range of services from process development to Current Good Manufacturing Practices (CGMP) clinical and commercial manufacturing of biologics for the biotechnology and biopharmaceutical industries. It operates in a single segment, which is contract manufacturing and development services. The Company’s services include clinical and commercial product manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The Company also provides a variety of process development services, including upstream and downstream development and optimization, analytical methods development, testing and characterization. It provides fully integrated and customized biomanufacturing services that support its customers from the early preclinical stage to commercial launch and supply.
Related indices
More about the company